NCR3 and chronic myelogenous leukemia, BCR-ABL1 positive: NCR3LG1 functions to encode the ligand of the natural cytotoxicity receptor NKp30 and knockdown of NCR3LG1 protects against cell death in the human chronic-myelogenous-leukemia (CML) cell line (42).